Post Operative Adjuvant Therapy De-intensification Trial for Human Papillomavirus-related, p16+ Oropharynx Cancer

NCT01687413 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

42

Enrollment

OTHER

Sponsor class

Stopped Slow accrual and funding issues

Conditions

Oropharyngeal Neoplasms

Interventions

RADIATION: Intensity-modulated radiation therapy (IMRT)
DRUG: Cisplatin

Sponsor

Washington University School of Medicine

Collaborators

[object Object]